As the BLT site states they are looking at 7 trial sites.
I suggest the more trial sites the better chance of finding suitable candidates in a larger pool.
Question, do they start from scratch, or will the new patients recieve the dosing of the second cohort?
No bad news here.
Status
TT-034 has entered a Phase l/lla human clinical trial:
- Benitec has two trial sites - Duke Clinical Research Centre where dosing has commenced and University of California San Diego which is recruiting.
- An additional five trial sites are being negotiated, with two expected to be operational in early 2015.
- Forums
- ASX - By Stock
- BLT
- Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL
Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL, page-5
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online